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Abstract
Background: In the new Stop TB Strategy for Tuberculosis (TB) Care, direct observation of
treatment has been replaced by "supervision and patient support". However, it is still unclear what
patient support means and how it is to be best implemented. The objective of this study was to
accurately document patients' support needs during TB treatment from their own perspectives, to
inform development of appropriate support and supervision strategies that meet patients' needs.
Methods: In-depth individual interviews and focus group discussions were conducted in three
districts in Nepal. Analysis took place concurrently with data collection to allow emerging issues
to guide selection of subsequent interviewees. In total 23 patients, 15 male and 8 female, were
interviewed and six focus group discussions were held. Issues from these interviews were grouped
into emergent themes.
Results: Respondents reported that the burden of treatment for TB was high, particularly in terms
of difficulties with social and psychological aspects of undergoing treatment. They saw three main
areas for support during their treatment: relevant information for them and their families about
their disease, its treatment, potential side-effects and what they should do if side-effects arise;
approachable and supportive healthcare staff with whom patients feel comfortable discussing (often
non-medical) problems that arise during treatment; and some flexibility in treatment to allow
essential elements of patients' lives (such as income generation, food-growing and childcare) to
continue. They were anxious to ensure that family support did not absolve healthcare workers
from their own support responsibilities.
Conclusion: In order to support people with TB more during their treatment, health policy and
practice must appreciate that TB affects all aspects of TB patients' lives. A focus on caring for each
patient as an individual should underlie all aspects of treatment. Improved communication between
healthcare providers and patients and increased patient knowledge and understanding of the
treatment programme would give those receiving treatment a sense of individual empowerment
and raise their confidence in treatment.
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Background
Tuberculosis is a profound and increasing global health
problem, with 9.27 million new cases and 1.6 million
deaths annually, with 1.058 million of these deaths occur-
ring in 22 high burden countries [1].
The Stop TB Strategy, launched in 2006, replaces supervi-
sion through direct observation during treatment by one
based around the provision of effective "supervision and
patient support" based upon effective two-way communi-
cation between healthcare providers and those receiving
treatment. [2] This patient-centred approach is also
reflected in both the International Standards for TB Care
(ISTC) and the Patients' Charter for TB Care. [3,4].
Increased patient empowerment may reduce the burden
to patients, increase case finding and promote treatment
completion. However, little operational research to docu-
ment patients' perspectives on provision of effective sup-
port has been undertaken. In response, we designed a
qualitative study in Nepal with the objective of identifying
the support needs of TB patients from their own perspec-
tives.
In Nepal, 63% of the population is infected with tubercu-
losis. Approximately 49 000 individuals develop active TB
and 6400 die annually [5]. Over a third of TB patients
have poor access to healthcare. Nepal is moving towards a
national strategy for a more patient-centred approach to
treatment, making it an appropriate environment in
which to study patient support during TB treatment.
Methods
We purposively selected three sites: Kathmandu; Kapil-
vastu district; and Baglung district (Table 1) to represent
different types of geographical sites with varying patient
demographics across Nepal. During August/September
2008, we carried out in-depth interviews to explore
respondent experiences with healthcare workers during
diagnosis and treatment; interaction with family and
community members during treatment; illness stigma;
and disease awareness and education. Following initial
interviews, subsequent questions were adjusted based on
emerging themes (Appendix 1). In total 23 patients (15
male and 8 female) attending their local healthcare facil-
ity were randomly selected, these numbers being chosen
to reflect the 2:1 male/female ratio of TB patients in Nepal
[5]. Of these patients, 15 were in the intensive phase (first
2 months) of treatment with the remainder 4 months into
their treatment programme. We also conducted six FGDs,
two of five women patients, two of five men patients, one
of local community members, and one of local commu-
nity medical assistants. In order to select patients for the
FGDs, the healthcare facility register was used to antici-
pate when individual patients would be attending clinic:
these patients were then approached and ask to form part
of a group discussion to be held at the healthcare facility.
During interviews and FGDs the interviewer/facilitator
took notes and made audio recordings which were then
transcribed, coded and grouped into emergent themes.
Approval for the research was granted by the National
Research Council of Nepal and a University of Leeds ethi-
cal committee. All respondents gave written informed
consent before each interview.
Results
1. Patients' interactions with healthcare workers
Individual interviewees and members of the patient FGDs
both voiced major concerns about a lack of individual
counselling during diagnosis and treatment, and poor
explanation of the treatment programme. The majority
placed emphasis upon not being given information about
the drug regimen and its potential side effects. The major-
ity reported they were spoken to for less than five minutes
at diagnosis. They were seldom given reasons for the long
duration of treatment, or told the importance of contin-
ued adherence and treatment completion. This under-
Table 1: General information about the three districts studied in Nepal (2006/07 data)
Urban Kathmandu Kapilvastu District Baglung District
Population 1,250,000 540,000 290,000
Geography Urban Plain Hill
Surface Area (km2) 395 1738 1784
Number of DOTS facilities 73 85 66
Case finding rate (%) 41 49 46
Treatment success (%) 84 84 85BMC Public Health 2009, 9:190 http://www.biomedcentral.com/1471-2458/9/190
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mined their confidence in the treatment programme and
left them reluctant to approach healthcare workers with
concerns. For example, a 26 year old woman described
how she knew very little about TB or its treatment. She
had received no clear information on why treatment took
so long, the importance of treatment adherence and com-
pletion or why her treatment was being supervised. She
observed, "I have no choice but to take the medication when
and where the people here tell me. I don't understand why I
have to take all these tablets every day for so long, but I have no
choice, I want to get better" (Patient 3, Kapilvastu). She had
little confidence in the healthcare centre staff or her treat-
ment, felt she had no say over her treatment and could not
approach healthcare staff with her concerns for fear of
recrimination.
The three individual respondents, who had received what
they considered a full and appropriate explanation of
their treatment felt confident in their treatment, were
more willing to approach healthcare workers with con-
cerns and felt they were active participants in their treat-
ment.
Two interviewees reported that they were having consider-
able problems with loss of vision and co-ordination. They
had not consulted healthcare workers because they did
not realise there were potential risks (and solutions). They
were adamant that they had never been told in detail
about the medication they were receiving, possible side-
effects, or what to do if they experienced side-effects.
The majority of respondents reported that treatment at the
healthcare facility was generally well tolerated because of
flexibility given to them by healthcare workers. Whilst the
guidelines of the National Tuberculosis Programme state
that treatment observation is to be carried out on a daily
basis [6], in practice the healthcare facility often allowed
some flexibility. Fifteen respondents reported that the role
and purpose of daily treatment observation was not
explained. Their interpretation was that they could not be
trusted to manage and complete their treatment. "The peo-
ple at the clinic don't think I will take my medication when I'm
supposed to ...They think we're all stupid and can't be trusted"
(Patient 2 Kapilvastu.)
Two respondents reported that they felt that being
allowed daily observation by a family member rather than
a health worker eliminated the constraints of facility-
based supervision, but meant that they received less sup-
port from the healthcare centre. One individual had dis-
continued treatment for a month because of severe side
effects before anyone from the healthcare centre followed
up on his non-appearance for a routine check up. He com-
mented, "The people at the hospital think they don't have to
worry about me because my family go and get my medicine for
me" (Patient 4, Baglung). Family members also described
that although they were supervising their relative's adher-
ence, they had received no education about TB and its
treatment, which they felt was essential to help them to
support their relative.
The majority of those interviewed both individually or as
part of a group discussion from across all three districts
shared concerns about lack of contact with healthcare staff
and a reluctance to approach them. An individual hospi-
talised with suspected multi-drug resistant (MDR) TB
described how in the three months he had been receiving
treatment he had hardly had any contact with healthcare
staff. He was very distressed: he described how he was
struggling to cope with his treatment, not only because of
his poor health, but also because he felt completely iso-
lated even though he was in a hospital surrounded by
healthcare workers. He commented, "Today is the longest
that anyone has spoken to me since they brought me into the
hospital because I was sick" (Patient 6, Baglung). He added
that there was nobody who could support him during his
time in hospital, and if he were strong enough he would
return home to his family who would help him more.
With his approval, we discussed with healthcare staff the
possibility of transferring the patient to his home village,
where he could receive the same level of medical treat-
ment but would be in a more supportive environment
with his close family. They responded, "... the patient gets
two meals a day and good medicine whilst he is here in hospital.
Moving him would take a lot of effort ... the hospital in X [his
home region] will just do what we are doing here" (discussion
with community medical assistant, Baglung).
2. Patients' interactions with family members
The majority of TB patients interviewed stated that during
their treatment programme they were most likely to dis-
close their TB status to close family members, who in turn
provided the highest level of support during treatment.
The majority of respondents did however say they often
felt considerable isolation, both physical and mental, due
respectively to precautions taken against disease spread
and because of a lack of understanding of TB. This isola-
tion from close family members was stated as being the
most difficult part of their treatment programme to deal
with on a day-to-day basis. Whilst individuals receiving
treatment often reported that they were motivated to com-
plete treatment, a sense of isolation in their family home,
and a lack of anyone to whom they felt they could relate
were the elements that had most affected their self-esteem,
made them feel most uncomfortable and made their treat-
ment experience most difficult. "Even people at home treat
me differently, whenever I cough everyone looks at me...they are
scared of me." (Patient 4 Kathmandu.) A number of these
individuals interviewed reported that it was difficult for
them to speak to family members about their problemsBMC Public Health 2009, 9:190 http://www.biomedcentral.com/1471-2458/9/190
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and concerns. Poor insight into TB and its treatment
meant that through no direct fault of their own, family
members could not provide the right type of support to
those undergoing treatment. This situation was high-
lighted during the patient FGDs, in which participants
spoke at length to each other about problems they were
having at home, and described that often family members
could not help them because they didn't understand their
situation.
Individuals who took part in these FGDs spoke afterwards
about how they felt better by just sitting and talking with
people in a similar position to themselves. Individual
group members stated that they could relate to other
group members better than those at home because of the
fact that they were all in a similar position. They said this
meant that they could understand each others' problems
much better. After two FGDs in Kathmandu, group mem-
bers exchanged phone numbers with a view to arranging
another ad-hoc meeting in the future.
Individuals receiving treatment said that they could be
supported more in their home if their family were better
educated about TB in general, allowing them to feel more
confident in sharing some of their concerns and feelings
during their treatment. Conversely, those few respondents
whose close family had a general understanding of TB
were more likely to share problems and concerns and
reported feeling less isolated, more motivated and better
understood.
3. Patients' interactions with the wider community
The majority of respondents believed that community
understanding of TB was poor. They reported that stigma
surrounding TB was high: because of this most had not
disclosed their TB status to any community members for
fear of discrimination towards themselves or their rela-
tives. The hospitalised MDR patient mentioned above
also described how when other TB patients heard of his TB
status, they had actively separated themselves from him,
speaking to him very little and had asked for his bed to be
moved away from theirs. This had a profound effect on
him in terms of his overall wellbeing and compounded
his feelings of isolation.
In two cases, respondents hid their disease because of a
fear of loss of employment if community members learnt
they had TB. "If the people who give me work find out that I
have TB they won't give me any more (work)....I have to think
about feeding my family and other things" (Patient 1 Kapil-
vastu). Some stated that they had delayed seeking diagno-
sis because of fear of the consequences of a diagnosis of
TB. A majority of respondents felt that high levels of TB
stigma were due to a fundamental lack of understanding
about TB. Healthcare workers reported that patients are
often very ill at the time of diagnosis because of an initial
reluctance to seek treatment. "It is too long (before some
patients come for treatment)...they wait too long, this means
that treating them is very difficult" (Community Medical
Assistant, Kapilvastu). Healthcare personnel felt this delay
was due to a lack of awareness of TB and also a fear of
community discrimination. Community healthcare work-
ers said that this delay was most marked in women due to
the local culture, commitments at home and very poor
awareness with regard to TB. This was a situation con-
firmed by individual interviews with those undergoing
treatment including a number of female interviewees.
Discussion
Our interviews show that a dichotomy exists between the
interpretations by patients and healthcare providers of
"supervision and patient support."
In order to better support people with TB during their
treatment, the healthcare system and its employees must
appreciate that TB disease affects all aspects of individuals'
lives, and must provide treatment programmes which rec-
ognise this. A focus by the healthcare system and its
employees on a biomedical model of treatment, concen-
trating primarily on accurate diagnosis and provision of
curative medicines, may show high levels of treatment
success as measured by routine programme statistics, but
this success is often at a considerable cost to patients.
Study participants report that the burden of treatment for
TB is high, particularly in terms of difficulties with social
and psychological aspects of undergoing treatment.
Whilst the Stop TB strategy requires that these aspects are
addressed in a more patient-centred approach to TB care,
they are not addressed or fully appreciated by the current
approach to TB control in Nepal, although there is now
movement towards a national strategy for a more patient-
centred approach.
Informal flexibility in treatment supervision is welcomed
by patients and has meant that a significant barrier to
seeking and continuing with effective TB treatment is
reduced. The results also support evidence provided by
studies in other low-income countries that by incorporat-
ing a degree of flexibility in treatment supervision, one of
the significant barriers to effective TB care can be removed
[6]. The feasibility of incorporating this approach into
treatment policy in Nepal, whilst ensuring that it does not
allow healthcare providers to compromise on patient
care, should be explored.
Our findings support current literature which reports that
health personnel involved in TB care are lacking in basic
communication skills [7]. Effective communication and
the establishment of good working relationships between
those with TB and healthcare providers, allowing patientsBMC Public Health 2009, 9:190 http://www.biomedcentral.com/1471-2458/9/190
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to feel they have an active role to play in their treatment as
encouraged in the Stop TB guidelines, should underlie TB
healthcare provision. This is supported by research which
shows that changing professional practice, leading to
improved quality of professional-patient interactions
results in an improvement in treatment adherence and
completion [8,9].
At diagnosis, an extended period of consultation with
more information being provided regarding TB and its
treatment would begin to establish a firmer relationship
between service users and providers. Discussion about the
medication the newly diagnosed individual is to receive,
an explanation of supervision and the importance of con-
tinued adherence would reassure patients and improve
their confidence in the TB treatment programme.
Improved awareness and understanding would also
increase the sense of empowerment that individuals with
TB feel in their roles as active participants in the treatment
process.
Those receiving treatment often feel that they currently
cannot approach healthcare workers with their concerns
and problems during treatment. Establishing a better
working relationship, in which the patient feels s/he is an
active participant, would help to improve this situation. It
would mean that problems which may arise during treat-
ment as a result of medication side-effects or other unre-
lated issues would not go unanswered, as is currently
often the case. This is supported by studies in other low-
income countries which show that where those receiving
treatment have an improved understanding of their drug
regimen, they default less, and are more likely to approach
healthcare workers if problems arise [10].
Looking to close family members for support during treat-
ment is not unique to those in Nepal [11]. Promoting
increased knowledge and awareness of a disease and its
treatment within a patient's family should form a key part
of effective healthcare policy for treatment of TB, as well
as other communicable diseases. A better understanding
of TB and its treatment within the families of those under-
going treatment would allow both parties to feel that they
could share their concerns and problems more openly.
This would help to remove the sense of isolation from
close family which respondents reported as being the
most difficult aspect of their treatment. The intensive
phase of treatment is the time when those receiving treat-
ment require most support. An opportunity for those
receiving treatment and close family members to receive
counselling together in consultation with a healthcare
worker following diagnosis during this time would allow
both these individuals to receive, and families to provide,
more support during the treatment programme.
In those cases where patient support is to be family-based,
healthcare staff should not view this arrangement as one
which absolves them of responsibility to an individual
with TB. For family based DOT to be successful requires
that the healthcare centre and staff supervise and support
the family members responsible for supporting the indi-
vidual undergoing treatment. Provision of counselling
both to those receiving treatment and those who are to be
supporting treatment is essential to ensure appropriate
support. This would not only improve confidence in treat-
ment but also allow treatment to become a partnership
between the patient and family members, enabling a
higher level of support, and improving the treatment
experience of all concerned.
Individuals receiving TB treatment say that they view a
lack of understanding of TB within both their family and
the wider community as a major reason why the treatment
period is one characterised by a distinct sense of isolation.
Providing a support network during treatment which
gives those undergoing treatment the opportunity to
speak to other patients currently receiving treatment is
one way that patients feel this sense of isolation can be
reduced. These groups could be established without plac-
ing significant increased demand on the healthcare centre
or its staff in terms of time or resources. This approach has
been documented in the literature as improving the treat-
ment experience for those receiving TB treatment [12].
The feasibility of a similar approach in Nepal warrants fur-
ther investigation.
Our findings add to the evidence which highlights issues
of stigma, poor understanding and awareness of TB and
problems with effective service provision as being major
reasons why many people with TB delay seeking TB diag-
nosis and treatment, affecting their treatment prognosis as
a result [13,14]. Interviews with TB patients and wider
community members show that it is healthcare workers
that people look towards to raise understanding and
awareness of TB. Investing more time in providing
patients with full and clear explanations about TB and its
treatment has been documented as being an effective
method of raising patients' levels of motivation and pro-
moting treatment adherence [15]. This research supports
these findings, adding that where proper information is
not given, patient confidence in their treatment pro-
gramme and by extension the healthcare centre and its
staff is low.
Conclusion
In order to support people with TB more during their
treatment, health policy and practice must appreciate that
TB affects all aspects of TB patients' lives. A focus on caring
for each patient as an individual should underlie all
aspects of treatment. We should ensure that all healthBMC Public Health 2009, 9:190 http://www.biomedcentral.com/1471-2458/9/190
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workers appreciate the difference between "TB patients"
and "people with TB", and its implications. It is important
that the healthcare system and its staff recognise that
improving a person's health requires more than just the
provision of effective medical treatment. Training health-
care workers in basic communication skills to promote
improved interaction between healthcare providers and
patients would result in a significant increase in patient
knowledge and understanding of their TB treatment pro-
gramme. It would give those receiving treatment for TB a
sense of individual empowerment, raising their confi-
dence in themselves and their treatment and significantly
improving their treatment experience as a result.
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Appendices
Appendix 1
TB Patients Questions
The following questions were used as a guide during patient
interviews. The questions were used for guidance of conversa-
tion and are not exhaustive.
Thoughts and Behaviours
• Can you describe to me what you think TB is?
￿ What do you understand about TB?
￿ Where did you learn about TB?
￿ What do you think causes TB? How is it spread and what
is the best way to treat it?
￿ How is TB understood in your community?
￿ Do patients with TB receive different treatment from
members of their family/community than those who
don't have the illness?
￿ Does TB stigma affect your motivation to seek treat-
ment?
￿ Do people in your community seek private treatment: if
so why?
Community and Family stigma
￿ Do you think that TB is well understood by your com-
munity and family?
￿ Can you describe how your family/friends/community/
employer reacted when you were diagnosed with TB?
￿ Can you describe how well TB and its treatment are
understood in your family/community?
￿ Who do you think might be in a good position to help
your community understand TB and its treatment better?
TB Education
￿ Can you describe what you were told about TB when
you came to the healthcare centre? Did the centre teach
you about the disease: if so how?
￿ Can you describe how you were taught about TB at the
healthcare centre?
￿ What do you feel could be done to help patients under-
stand their TB treatment better?
TB Medication
￿ Can you describe to me how you were taught about your
medication which will help to treat your illness?
￿ Have you had any problems with your medication?
￿ Can you describe to me if you were taught about some
of the side-effects that you might get from your medica-
tion and how you might be able to reduce them?
￿ Do you understand what side-effects are serious and
when you should return to the healthcare centre?
TB Treatment
￿ Please describe for me your TB treatment programme.
￿ Please describe some of the difficulties that you have
had while you have been receiving treatment.
￿ Please describe how you were told about your treatment.
￿ Do you understand why treatment is so long?
￿ Do you understand why it is important to take your
treatment even when you feel better?
￿ Do you understand the benefits to the health of your
family and community that will happen if you complete
your treatment; if not would this change your attitude to
treatment?BMC Public Health 2009, 9:190 http://www.biomedcentral.com/1471-2458/9/190
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￿ Do you talk to other members of your family/commu-
nity about your treatment; do they understand your treat-
ment?
￿ What changes would make your treatment experience
better?
Motivation
￿ Do you think you will be able to complete your treat-
ment which will last for 6 months? Why?
￿ Can you describe the support that you have received
during your illness and as you have started getting treat-
ment from your family/community/healthcare centre?
￿ What do you think would make your long treatment
programme easier for you?
￿ If patients were given something for completing their
treatment that would help people to finish their treat-
ment?
Supervision
￿ Why do you think that your treatment is supervised?
￿ Do you think that this supervision helps you to continue
with your treatment?
￿ Do you feel you have any say about your treatment?
￿ Have you ever talked to the healthcare centre about
some of your difficulties? How do they react?
￿ What changes would make your treatment experience
better?
￿ How would you like to be treated: the NTP says that you
must be supervised in some way, how do you think this
might be done?
Family Support
￿ Please describe to me the support you have received
from you family during your treatment
￿ Do you think that the attitude of your family has
changed since you were diagnosed with TB
Healthcare Centre Support
￿ Please describe to me the support you received from the
healthcare centre when you were first diagnosed. How did
they help you?
￿ What do you think the healthcare centre could do to
help you more?
￿ Can you describe to me how you are treated when you
come to the centre each time?
￿ Can you describe how the centre supports you to con-
tinue with your treatment?
Community Support
￿ Please describe to me the support you get from your
community. How do they help you with your treatment?
￿ When somebody is diagnosed with TB, does the attitude
of your family/community change towards them? Why?
￿ Do you feel you are treated differently by your commu-
nity now that you are getting your treatment?
￿ Who in your community is well respected? Who do peo-
ple look up to for help when they need support?
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